Andrew J. Fisher

From rejection to vasculopathy: a review of non-invasive biomarkers in alloimmune responses in heart transplantation

Non-invasive biomarkers have meaningfully advanced rejection surveillance in heart transplantation and hold promise for reducing procedural burden on patients, however, their role in detecting and monitoring CAV remains underdeveloped, and represents the most critical unmet need in the field.